rs148877451

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000292.3(PHKA2):​c.2361-12A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00535 in 1,203,196 control chromosomes in the GnomAD database, including 221 homozygotes. There are 1,689 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.027 ( 112 hom., 785 hem., cov: 23)
Exomes 𝑓: 0.0031 ( 109 hom. 904 hem. )

Consequence

PHKA2
NM_000292.3 intron

Scores

2
Splicing: ADA: 0.00002485
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -1.99

Publications

1 publications found
Variant links:
Genes affected
PHKA2 (HGNC:8926): (phosphorylase kinase regulatory subunit alpha 2) Phosphorylase kinase is a polymer of 16 subunits, four each of alpha, beta, gamma and delta. The alpha subunit includes the skeletal muscle and hepatic isoforms, and the hepatic isoform is encoded by this gene. The beta subunit is the same in both the muscle and hepatic isoforms, and encoded by one gene. The gamma subunit also includes the skeletal muscle and hepatic isoforms, which are encoded by two different genes. The delta subunit is a calmodulin and can be encoded by three different genes. The gamma subunits contain the active site of the enzyme, whereas the alpha and beta subunits have regulatory functions controlled by phosphorylation. The delta subunit mediates the dependence of the enzyme on calcium concentration. Mutations in this gene cause glycogen storage disease type 9A, also known as X-linked liver glycogenosis. Alternatively spliced transcript variants have been reported, but the full-length nature of these variants has not been determined.[provided by RefSeq, Feb 2010]
PHKA2 Gene-Disease associations (from GenCC):
  • glycogen storage disease IXa1
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp
  • glycogen storage disease due to liver phosphorylase kinase deficiency
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.68).
BP6
Variant X-18908068-T-G is Benign according to our data. Variant chrX-18908068-T-G is described in ClinVar as Benign. ClinVar VariationId is 255772.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0922 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PHKA2NM_000292.3 linkc.2361-12A>C intron_variant Intron 21 of 32 ENST00000379942.5 NP_000283.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PHKA2ENST00000379942.5 linkc.2361-12A>C intron_variant Intron 21 of 32 1 NM_000292.3 ENSP00000369274.4

Frequencies

GnomAD3 genomes
AF:
0.0274
AC:
3057
AN:
111371
Hom.:
112
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.0952
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00825
Gnomad ASJ
AF:
0.000380
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000164
Gnomad MID
AF:
0.00847
Gnomad NFE
AF:
0.000491
Gnomad OTH
AF:
0.0200
GnomAD2 exomes
AF:
0.00844
AC:
1546
AN:
183079
AF XY:
0.00569
show subpopulations
Gnomad AFR exome
AF:
0.102
Gnomad AMR exome
AF:
0.00529
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000441
Gnomad OTH exome
AF:
0.00530
GnomAD4 exome
AF:
0.00309
AC:
3376
AN:
1091773
Hom.:
109
Cov.:
30
AF XY:
0.00253
AC XY:
904
AN XY:
357229
show subpopulations
African (AFR)
AF:
0.101
AC:
2664
AN:
26289
American (AMR)
AF:
0.00565
AC:
199
AN:
35202
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19342
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30191
South Asian (SAS)
AF:
0.000315
AC:
17
AN:
53974
European-Finnish (FIN)
AF:
0.0000494
AC:
2
AN:
40482
Middle Eastern (MID)
AF:
0.00413
AC:
17
AN:
4112
European-Non Finnish (NFE)
AF:
0.000214
AC:
179
AN:
836299
Other (OTH)
AF:
0.00649
AC:
298
AN:
45882
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
131
262
392
523
654
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
80
160
240
320
400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0275
AC:
3060
AN:
111423
Hom.:
112
Cov.:
23
AF XY:
0.0233
AC XY:
785
AN XY:
33697
show subpopulations
African (AFR)
AF:
0.0951
AC:
2913
AN:
30627
American (AMR)
AF:
0.00824
AC:
87
AN:
10562
Ashkenazi Jewish (ASJ)
AF:
0.000380
AC:
1
AN:
2629
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3503
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2609
European-Finnish (FIN)
AF:
0.000164
AC:
1
AN:
6114
Middle Eastern (MID)
AF:
0.00926
AC:
2
AN:
216
European-Non Finnish (NFE)
AF:
0.000491
AC:
26
AN:
52963
Other (OTH)
AF:
0.0198
AC:
30
AN:
1518
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
107
214
321
428
535
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
30
60
90
120
150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0117
Hom.:
60
Bravo
AF:
0.0313

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Mar 13, 2017
Mayo Clinic Laboratories, Mayo Clinic
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

May 03, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
Mar 14, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Glycogen storage disease IXa1 Benign:1
Dec 13, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.68
CADD
Benign
0.35
DANN
Benign
0.70
PhyloP100
-2.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000025
dbscSNV1_RF
Benign
0.060
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs148877451; hg19: chrX-18926186; API